Can a med spa in Idaho offer compounded semaglutide or tirzepatide?
Facility · part of The Practice Perimeter
Short answer
The cited rules do not settle this — compounding is defined as tailoring a drug to one named patient (no office stock), and a clinic that sends a vial home becomes a prescriber drug outlet needing board registration; injecting on site is not dispensing.
Compounded semaglutide or tirzepatide exists in Idaho only as a preparation for one named patient, and the definition of compounding is where the law says so. "Compounding" means the practice in which a pharmacist, a prescriber, or, in the case of an outsourcing facility, a person under the supervision of a pharmacist combines, mixes or alters ingredients of a drug to create a medication tailored to the needs of an individual patient. A prescriber is named in the definition, so compounding is not a pharmacist-only act here — but the preparation must be tailored to an individual patient, and this definition describes no office stock.
Idaho Code § 54-1704(7) (definition of “Compounding”) · verified Sep 6, 2026 · regulatory monitoring, not legal advice
Related Idaho rules
A 503B outsourcing facility supplying compounded semaglutide into Idaho must clear TWO registrations, not one. "Outsourcing facility" means a pharmacy or facility that is registered by the federal food and drug administration pursuant to 21 U.S.C. 353b and either registered or endorsed by the board. FDA registration alone does not reach Idaho patients; the board must also have registered or endorsed the facility.
Idaho Code § 54-1704(34) (definition of “Outsourcing facility”) · verified Sep 6, 2026
And the carve-out is the whole distinction for a med spa: injecting in clinic is not dispensing. The definition applies "except where delivery is accomplished only through on-site administration or the provision of drug samples, patient assistance program drugs, or investigational drugs as permitted in chapter 94, title 39 , Idaho Code." A clinic that draws up and injects the dose itself is delivering by on-site administration and falls outside this definition; a clinic that sends the patient home with a vial of compounded semaglutide is dispensing, and is a prescriber drug outlet.
Idaho Code § 54-1704(45) (…except where delivery is only on-site administration) · verified Sep 6, 2026
How other states answer this
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Related Idaho questions
- Is an exam required before a patient can be treated in Idaho?
- Can the pre-treatment exam be done by telehealth in Idaho?
Get Idaho changes as they publish
We scan the Idaho legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
← All Idaho rules and changes · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director. Legislative data via LegiScan (CC BY 4.0).